Skip Navigation


Human Reproduction Update Advance Access originally published online on September 23, 2004
Human Reproduction Update 2004 10(6):453-467; doi:10.1093/humupd/dmh044
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
10/6/453    most recent
dmh044v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lunenfeld, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lunenfeld, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction Update vol. 10 no. 6 © European Society of Human Reproduction and Embryology 2004; all rights reserved

Historical perspectives in gonadotrophin therapy

Bruno Lunenfeld

Faculty of Life Sciences, Bar-Ilan University, Ramat Gan 52900, Israel

The 20th century witnessed the steady development of knowledge about the reproductive process in animals and humans. These advances led to the identification of higher centres governing the dynamics of ovarian function and to the discovery of gonadotrophic hormones. As the mechanisms of action of these hormones became increasingly understood, they began to be used in the management of infertility during the early 1930s. Hormone extracts were originally prepared from animal pituitaries and pregnant mare serum, as well as from human pituitaries, placenta and urine, with pregnancies reported following their use in the late 1930s. This review traces the constant quest to reduce risks and improve safety and efficacy of hormone preparations for patients. It describes the complex path and perils leading to the pure hormone preparations that are available today, concluding with an optimistic glimpse towards the future. Small molecules that are orally active and specific are currently being investigated, some with the capacity to bypass many parts of the receptor conformation. Here lies the immediate future of this field, utilizing low-cost, small, defined molecules to stimulate follicle growth, ovulation and corpus luteum formation. Perhaps one day the classical gonadotrophins will no longer be required in clinical treatment.

Key words: gonadotrophin preparations / history / hMG / ovarian stimulation / rFSH


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
B.C.J.M. Fauser, B.M.J.L. Mannaerts, P. Devroey, A. Leader, I. Boime, and D.T. Baird
Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency
Hum. Reprod. Update, May 1, 2009; 15(3): 309 - 321.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
The ESHRE Capri Workshop Group
Intrauterine insemination
Hum. Reprod. Update, May 1, 2009; 15(3): 265 - 277.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
R. Calderon-Margalit, Y. Friedlander, R. Yanetz, K. Kleinhaus, M. C. Perrin, O. Manor, S. Harlap, and O. Paltiel
Cancer Risk After Exposure to Treatments for Ovulation Induction
Am. J. Epidemiol., February 1, 2009; 169(3): 365 - 375.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
E. P Lemke, B. M Adams, A. Jablonka-Shariff, I. Boime, and T. E Adams
Single-chain human gonadotropin analogs induce follicle development in sheep
J. Endocrinol., March 1, 2008; 196(3): 593 - 600.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. M. Garone, E. Ammannati, T. S. Brush, D. J. Fischer, E. G. Tos, J. Luo, K. L. Altobello, C. Ciampolillo, T. M. Ihley, E. Kurosawa, et al.
Biological Properties of a Novel Follicle-Stimulating Hormone/Human Chorionic Gonadotropin Chimeric Gonadotropin
Endocrinology, September 1, 2006; 147(9): 4205 - 4212.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Endocr. Rev., April 1, 2006; 27(2): 170 - 207.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.